Condition
Transformed Non-Hodgkin Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Transformed Non-Hodgkin Lymphoma clinical trials that are recruiting, at sites in 2 countries (most in United States (3), New Zealand (1)). By phase: Phase 2 (2), Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Transformed Non-Hodgkin Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Treatment of relapsed large B-cell lymphoma with WZTL-002 CAR T-cells | Phase 2 | Auckland, Auckland and 2 other locations | Recruiting | Jul 3, 2024 |
| Combining new drugs with standard treatment for relapsed large B-cell lymphoma | Phase 2 | Tucson, Arizona and 103 other locations | Recruiting | Jun 6, 2023 |
| Using genetically modified T-cells and a vaccine to treat certain types of B-cell lymphoma after stem cell transplantation | Phase 1 | Duarte, California | Recruiting | Jun 27, 2022 |
| Using stem cell transplant and Polatuzumab Vedotin for treating B-cell lymphomas | Phase 1/2 | Valhalla, New York | Recruiting | Jul 29, 2020 |
All recruiting trials (4)
-
Treatment of relapsed large B-cell lymphoma with WZTL-002 CAR T-cells
This study is testing a new CAR T-cell therapy called WZTL-002 to see if it can help adults with relapsed large B-cell lymphoma that hasn't worked with standard chemotherapy.
-
Combining new drugs with standard treatment for relapsed large B-cell lymphoma
This study is testing a new combination of drugs for people with large B-cell lymphoma that has come back or didn’t get better with earlier treatments to see if it works better than the usual options.
-
Using genetically modified T-cells and a vaccine to treat certain types of B-cell lymphoma after stem cell transplantation
This study is testing a new treatment using specially modified immune cells and a vaccine to see if it can help people with certain types of B-cell lymphoma after they've had a stem cell transplant.
-
Using stem cell transplant and Polatuzumab Vedotin for treating B-cell lymphomas
This study is testing if a stem cell transplant followed by a new drug called Polatuzumab Vedotin can help people with different types of B-cell lymphomas feel better.
Related topics
Quick answers
How many Transformed Non-Hodgkin Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.